Biomoda CEO Discusses Top Line Results

Biomoda (OTCBB: BMOD) released top line results of the Company’s pilot clinical trials for its CyPath diagnostic for lung cancer.  The results were statistically significant and the Company’s CEO, Maria Zannes, was a featured interview on several nationally syndicated business talk radio shows.  These interviews are archived on the Biomoda’s website, www.biomoda.com.

Read More

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: